SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 174 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $269,000 | -8.5% | 208,565 | -9.8% | 0.00% | – |
Q4 2021 | $294,000 | -42.0% | 231,245 | -0.6% | 0.00% | – |
Q3 2021 | $507,000 | -46.6% | 232,695 | -8.2% | 0.00% | – |
Q2 2021 | $950,000 | +31.8% | 253,385 | +14.5% | 0.00% | – |
Q1 2021 | $721,000 | -4.4% | 221,285 | +0.1% | 0.00% | – |
Q4 2020 | $754,000 | -25.9% | 221,035 | -11.4% | 0.00% | -100.0% |
Q3 2020 | $1,018,000 | +23.7% | 249,535 | +2.4% | 0.00% | – |
Q2 2020 | $823,000 | +43.1% | 243,595 | -1.3% | 0.00% | – |
Q1 2020 | $575,000 | -10.3% | 246,725 | +40.2% | 0.00% | – |
Q4 2019 | $641,000 | -55.9% | 175,975 | +0.4% | 0.00% | -100.0% |
Q3 2019 | $1,454,000 | -14.8% | 175,275 | -11.6% | 0.00% | 0.0% |
Q2 2019 | $1,707,000 | -2.5% | 198,275 | +21.1% | 0.00% | 0.0% |
Q1 2019 | $1,750,000 | +22.2% | 163,675 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $1,432,000 | -74.5% | 163,675 | -50.9% | 0.00% | -75.0% |
Q3 2018 | $5,606,000 | +25.2% | 333,675 | +56.2% | 0.00% | +33.3% |
Q2 2018 | $4,479,000 | +128.8% | 213,675 | +75.6% | 0.00% | +200.0% |
Q1 2018 | $1,958,000 | -22.5% | 121,675 | -8.8% | 0.00% | -50.0% |
Q4 2017 | $2,527,000 | +116.0% | 133,375 | +60.4% | 0.00% | +100.0% |
Q3 2017 | $1,170,000 | +88.7% | 83,175 | 0.0% | 0.00% | – |
Q2 2017 | $620,000 | +14.6% | 83,175 | 0.0% | 0.00% | – |
Q1 2017 | $541,000 | +47.0% | 83,175 | 0.0% | 0.00% | – |
Q4 2016 | $368,000 | -5.2% | 83,175 | 0.0% | 0.00% | – |
Q3 2016 | $388,000 | -28.9% | 83,175 | 0.0% | 0.00% | – |
Q2 2016 | $546,000 | +13.0% | 83,175 | +9.5% | 0.00% | – |
Q1 2016 | $483,000 | +5.5% | 75,975 | 0.0% | 0.00% | – |
Q4 2015 | $458,000 | +0.9% | 75,975 | 0.0% | 0.00% | – |
Q3 2015 | $454,000 | -12.7% | 75,975 | -0.1% | 0.00% | – |
Q2 2015 | $520,000 | -5.1% | 76,065 | -15.7% | 0.00% | – |
Q1 2015 | $548,000 | -13.3% | 90,265 | -1.1% | 0.00% | -100.0% |
Q4 2014 | $632,000 | -27.4% | 91,248 | -14.8% | 0.00% | 0.0% |
Q3 2014 | $871,000 | +0.1% | 107,048 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $870,000 | +3.7% | 107,048 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $839,000 | -11.5% | 107,048 | -0.0% | 0.00% | 0.0% |
Q4 2013 | $948,000 | +5.5% | 107,086 | -0.0% | 0.00% | 0.0% |
Q3 2013 | $899,000 | +12.5% | 107,098 | -0.0% | 0.00% | 0.0% |
Q2 2013 | $799,000 | – | 107,135 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |